{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T02:47:24Z","timestamp":1772160444072,"version":"3.50.1"},"reference-count":14,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":2161,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1111\/j.1365-2133.2009.09331.x","type":"journal-article","created":{"date-parts":[[2009,6,5]],"date-time":"2009-06-05T03:24:20Z","timestamp":1244172260000},"page":"797-800","source":"Crossref","is-referenced-by-count":84,"title":["Tuberculosis screening in patients with psoriasis before antitumour necrosis factor therapy: comparison of an interferon-\u03b3 release assay vs. tuberculin skin test"],"prefix":"10.1093","volume":"161","author":[{"given":"E.","family":"Laffitte","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.P.","family":"Janssens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Roux-Lombard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.M.","family":"Thielen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Barde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Marazza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.G.","family":"Panizzon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-H.","family":"Saurat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","reference":[{"key":"10.1111\/j.1365-2133.2009.09331.x-BIB1","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/BOR.0b013e3283025ec2","article-title":"Tuberculosis reactivation during immunosuppressive therapy in rheumatic diseases: diagnostic and therapeutic strategies","volume":"20","author":"Keane","year":"2008","journal-title":"Curr Opin Rheumatol"},{"key":"10.1111\/j.1365-2133.2009.09331.x-BIB2","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S1473-3099(03)00545-0","article-title":"Antitumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management","volume":"3","author":"Gardam","year":"2003","journal-title":"Lancet Infect Dis"},{"key":"10.1111\/j.1365-2133.2009.09331.x-BIB3","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.clim.2007.08.012","article-title":"TNFalpha blockade in human diseases: an overview of efficacy and safety","volume":"126","author":"Lin","year":"2008","journal-title":"Clin Immunol"},{"key":"10.1111\/j.1365-2133.2009.09331.x-BIB4","first-page":"1127","article-title":"Tuberculosis in patients receiving anti-TNF agents despite chemoprophylaxis","volume":"10","author":"Sichletidis","year":"2006","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1111\/j.1365-2133.2009.09331.x-BIB5","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1136\/thx.2005.046797","article-title":"BTS recommendations for assessing risk and for managing Mycobacterium\u00a0tuberculosis infection and disease in patients due to start anti-TNF-alpha treatment","volume":"60","author":"British Thoracic Society Standards of Care Committee","year":"2005","journal-title":"Thorax"},{"key":"10.1111\/j.1365-2133.2009.09331.x-BIB6","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jaad.2008.03.023","article-title":"National Psoriasis Foundation consensus statement on screening for latent tuberculosis infection in patients with psoriasis treated with systemic and biologic agents","volume":"59","author":"Doherty","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09331.x-BIB7","unstructured":"7Centers for Disease Control and Prevention. Guide for primary health care providers: targeted tuberculin testing and treatment of latent tuberculosis infection. Available at: http:\/\/www.cdc.gov\/tb\/publications\/LTBI\/pdf\/TargetedLTBI05.pdf (last accessed 10 June 2009)."},{"key":"10.1111\/j.1365-2133.2009.09331.x-BIB8","doi-asserted-by":"crossref","first-page":"340","DOI":"10.7326\/0003-4819-146-5-200703060-00006","article-title":"Meta-analysis: new tests for the diagnosis of latent tuberculosis infection: areas of uncertainty and recommendations for research","volume":"146","author":"Menzies","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1365-2133.2009.09331.x-BIB9","first-page":"49","article-title":"Guidelines for using the QuantiFERON-TB Gold test for detecting Mycobacterium\u00a0tuberculosis infection, United States","volume":"54","author":"Mazurek","year":"2005","journal-title":"MMWR Recomm Rep"},{"key":"10.1111\/j.1365-2133.2009.09331.x-BIB10","unstructured":"10National Institute for Health and Clinical Excellence. Tuberculosis. Clinical Diagnosis and Management of tuberculosis, and measures for its prevention and control. Available at: http:\/\/www.nice.org.uk\/CG033. Last updated March 2006 (last accessed 10 June 2009)."},{"key":"10.1111\/j.1365-2133.2009.09331.x-BIB11","first-page":"620","article-title":"Screening for tuberculosis infection before the initiation of an anti-TNF-alpha therapy","volume":"137","author":"Beglinger","year":"2007","journal-title":"Swiss Med Wkly"},{"key":"10.1111\/j.1365-2133.2009.09331.x-BIB12","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1111\/j.1365-2133.2008.08457.x","article-title":"QuantiFERON-TB Gold testing for tuberculosis in psoriasis patients commencing antitumour necrosis factor alpha therapy","volume":"158","author":"Desai","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1365-2133.2009.09331.x-BIB13","first-page":"S126","article-title":"Tuberculosis and opportunistic infections: relevance to biologic agents","volume":"22","author":"Bieber","year":"2004","journal-title":"Clin Exp Rheumatol"},{"key":"10.1111\/j.1365-2133.2009.09331.x-BIB14","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/art.22768","article-title":"Risk of tuberculosis in patients treated with tumor necrosis factor antagonists due to incomplete prevention of reactivation of latent infection","volume":"57","author":"Gomez-Reino","year":"2007","journal-title":"Arthritis Rheum"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.2009.09331.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2133.2009.09331.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T08:46:06Z","timestamp":1676364366000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/161\/4\/797\/6642144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,10]]},"references-count":14,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,10]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2133.2009.09331.x","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1167973.630077","asserted-by":"object"}]},"ISSN":["0007-0963","1365-2133"],"issn-type":[{"value":"0007-0963","type":"print"},{"value":"1365-2133","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,10]]}}}